Skip to content
Recall Observatory FDA recall evidence

Drug product

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

D-0130-2025

December 12, 2024

Class II

Product summary

Firm
Ascend Laboratories, LLC
Event
Event 95896
Status
Ongoing
Classification
Class II
Quantity
10,444 bottles
Official record key
drug-enforcement:D-0130-2025

Official wording

Reason: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

Code information: Lot #: 24142192, 24142193, 24142194, Exp. Date April 30, 2026; 24142463, Exp. Date May 31, 2026;

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-Dabigatran impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations